TAK-781
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-781, covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC) [Phase 1]